,i  #aafth ,,congress  #ast ,session    
,h4 ,r4 #behb  ,,in ,,the ,,house ,,of  
,,representatives  ,may #h1 #bjai,mr4   
,cicilline introduced the following     
bill2 which was referred to the         
,committee on ,energy and ,commerce1 and
 in addition to the ,committee on the   
,judiciary1 for a period to be          
subsequently determined by the ,speaker1
 in each case for consideration of such 
provisions as fall within the           
jurisdiction of the committee concerned 
,a ,,bill  ,to amend the ,controlled    
,substances ,act to require the         
,attorney ,general to make procurement  
quotas for opioid analgesics publicly   
available1 and for other purposes4  #a4 
,short title ,this ,act may be cited as 
the ,opioid ,quota ,openness1           
,transparency1 and ,awareness ,act of   
#bjai or the ,opioid ,qu,o,t,a ,act4    
#b4 ,public reporting of procurement    
quotas for opioid analgesics  7a7 ,in   
general ,section #cjf of the ,controlled
 ,substances ,act 7#ba ,u4,s4,c4 #hbf7  

is amended by adding at the end the     
following3  7j7  7#a7 ,in this          
subsection1 the term opioid procurement 
quota means a quota established by the  
,attorney ,general for the quantity of  
opioid analgesics that a registered     
manufacturer may procure for purposes of
 manufacturing dosage forms or other    
substances4  7#b7 ,the ,attorney        
,general shall make publicly available1 
including through the ,web site of the  
,drug ,enforcement ,administration--    
7,a7 the quantity of the opioid         
procurement quota for each registered   
manufacturer for each year2  7,b7 the   
quantity of opioid analgesics procured  
by each registered manufacturer for each
 year2 and  7,c7 except as provided     
under paragraph 7#c7-- 7i7 a copy of the
 form or other application1 including   
any attachments or exhibits1 submitted  
by each registered manufacturer         
requesting an opioid procurement quota2 
and  7ii7 a copy of each year-end or    
annual report relating to the           

procurement or use of opioid analgesics 
submitted to the ,attorney ,general by a
 registered manufacturer to whom the    
,attorney ,general has issued an opioid 
procurement quota4  7#c7 ,upon a request
 by a registered manufacturer asserting 
that a document or information described
 in clause 7i7 or 7ii7 of paragraph     
7#b77;,c7 is exempt from disclosure     
under section #eeb7;b77#d7 of title #e1 
,united ,states ,code1 and to the extent
 that the ,attorney ,general determines 
that the document or information is     
exempt from disclosure under such       
section #eeb7;b77#d71 the document or   
information may be excluded from public 
disclosure under paragraph 7#b74  4  7b7
 ,,gao report ,the ,comptroller ,general
 of the ,united ,states shall submit to 
,congress a report that1 for the #a-year
 period beginning on the date of        
enactment of this ,act--  7#a7 details--
 7,a7 the number of instances in which a
 registered manufacturer made a request 
described in section #cjf7;j77#c7 of the

 ,controlled ,substances ,act1 as added 
by subsection 7a71 with respect to a    
document or information2 and  7,b7 the  
number of instances in which the        
,attorney ,general determined such a    
document or information was exempt from 
disclosure under section #eeb7;b77#d7 of
 title #e1 ,united ,states ,code2 and   
7#b7 evaluates the extent of the        
independent evaluation conducted by the 
,attorney ,general of requests described
 in section #cjf7;j77#c7 of the         
,controlled ,substances ,act4